Su-Ni Tang Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

10/2014	Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
1/2014	Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.
1/2014	Embelin suppresses pancreatic cancer growth by modulating tumor immune microenvironment.
9/2013	Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
7/2012	Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
1/2012	EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.
1/2011	Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
1/2011	Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.
1/2011	Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su-Ni Tang Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 08/2010
9	Pancreatic Neoplasms (Pancreatic Cancer) 10/2014 - 01/2011
8	Neoplasm Metastasis (Metastasis) 01/2017 - 08/2010
3	Adenocarcinoma 01/2021 - 09/2015
3	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 08/2010
3	Carcinogenesis 01/2017 - 07/2012
2	Neuroendocrine Carcinoma 01/2021 - 12/2016
2	Inflammation (Inflammations) 09/2015 - 01/2014
1	Body Weight (Weight, Body) 11/2018

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2018 - 08/2010
4	Cyclin D1IBA 10/2014 - 09/2013
3	Messenger RNA (mRNA)IBA 01/2021 - 09/2015
3	decursinIBA 01/2021 - 09/2015
3	PyranocoumarinsIBA 01/2021 - 09/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 09/2013
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2017
2	Androgen Receptors (Androgen Receptor)IBA 11/2018 - 01/2017
2	embelinIBA 01/2014 - 01/2014
2	Caspase 3 (Caspase-3)IBA 01/2014 - 09/2013
2	FlavonoidsIBA 01/2011 - 08/2010
2	QuercetinIBA 01/2011 - 08/2010
2	beta CateninIBA 01/2011 - 08/2010
2	VimentinIBA 01/2011 - 08/2010
1	LipidsIBA 01/2021
1	Nuclear Receptor Coactivator 1IBA 11/2018
1	CaspasesIBA 11/2018
1	Cardiotonic Agents (Cardiac Stimulants)IBA 11/2018
1	GalactosidasesIBA 11/2018
1	bufalinIBA 11/2018
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 12/2016
1	ProdrugsIBA 09/2015
1	rottlerinIBA 10/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	Ellagic AcidIBA 09/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2012
1	Gemcitabine FDA Link 01/2012
1	tofacitinibIBA 01/2012
1	Aldehyde DehydrogenaseIBA 01/2011
1	ResveratrolIBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	PolyphenolsIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	ChromatinIBA 01/2011
1	Vorinostat FDA Link 01/2011
1	Decitabine FDA Link 01/2011
1	sulforaphaneIBA 01/2011
1	SuspensionsIBA 08/2010

Therapy/Procedure

3	Therapeutics 11/2018 - 07/2012
1	Intraperitoneal Injections 11/2018
1	Drug Therapy (Chemotherapy) 01/2011